Viewing Study NCT06109467


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-02-25 @ 5:48 PM
Study NCT ID: NCT06109467
Status: RECRUITING
Last Update Posted: 2025-12-04
First Post: 2023-10-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module